Skip to main content
Erschienen in: Rheumatology International 6/2012

01.06.2012 | Original Article

Characteristics and influence factors of pathologic transformation in the subclasses of class IV lupus nephritis

verfasst von: Jian-jun Gao, Guang-yan Cai, Shu-wen Liu, Li Tang, Xue-guang Zhang, Yang Yang, Pu Chen, Shu-xin Liu, Jia-yao Ji, Suo-zhu Shi, Zhong Yin, Xiang-mei Chen

Erschienen in: Rheumatology International | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

The study explored the characteristics and correlation factors of transformation in subclasses of class IV lupus nephritis. Patients with class IV lupus nephritis were subjected to repeat biopsies after 6 months of induction treatment. Transformation rate between two subclasses, class IV-S and class IV-G, was compared. Influence Factors of transformation were evaluated. Class IV-G had more severe hypertension and higher score of immunofluorescence index, glomerular active lesions, tubular and vascular lesions. Class IV-S had a higher percentage of glomerular fibrinoid necrosis. Class IV-S appeared a higher rate of transformation to class II than class IV-G (57% vs. 27%). In each subclass, active lesion also showed a higher rate of transformation to class II than active/chronic lesion (IV-G: 41.2% vs. 12.5%; IV-S: 71.4% vs. 42.8%). Patients who maintained class IV had higher blood pressure, obvious proteinuria, declined kidney function, and lower C3 level. Immunosuppressive therapy, urine protein, and vascular lesions were independent risk factors for the pathologic transformation. The rate of transformation in class IV-S was higher than that in class IV-G. The transformation is most likely to benefit from immunosuppressive therapy. Urine protein and vascular lesions are correlated with the transformation in class IV lupus nephritis.
Literatur
1.
Zurück zum Zitat Cameron JS (1999) Lupus nephritis. J Am Soc Nephrol 10(2):413–424PubMed Cameron JS (1999) Lupus nephritis. J Am Soc Nephrol 10(2):413–424PubMed
2.
Zurück zum Zitat Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15(2):241–250PubMedCrossRef Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15(2):241–250PubMedCrossRef
3.
Zurück zum Zitat Hiramatsu N, Kuroiwa T, Ikeuchi H, Maeshima A, Kaneko Y, Hiromura K et al (2008) Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions. Rheumatology (Oxford) 47(5):702–707CrossRef Hiramatsu N, Kuroiwa T, Ikeuchi H, Maeshima A, Kaneko Y, Hiromura K et al (2008) Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions. Rheumatology (Oxford) 47(5):702–707CrossRef
4.
Zurück zum Zitat Schwartz MM, Korbet SM, Lewis EJ, Roberts JL, Rodby RA, Corwin HL et al (2008) The prognosis and pathogenesis of severe lupus glomerulonephritis. Nephrol Dial Transplant 23(4):1298–1306PubMedCrossRef Schwartz MM, Korbet SM, Lewis EJ, Roberts JL, Rodby RA, Corwin HL et al (2008) The prognosis and pathogenesis of severe lupus glomerulonephritis. Nephrol Dial Transplant 23(4):1298–1306PubMedCrossRef
5.
Zurück zum Zitat Magil AB, Puterman ML, Ballon HS, Chan V, Lirenman DS, Rae A et al (1988) Prognostic factors in diffuse proliferative lupus glomerulonephritis. Kidney Int 34(4):511–517PubMedCrossRef Magil AB, Puterman ML, Ballon HS, Chan V, Lirenman DS, Rae A et al (1988) Prognostic factors in diffuse proliferative lupus glomerulonephritis. Kidney Int 34(4):511–517PubMedCrossRef
6.
Zurück zum Zitat Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). Am J Kidney Dis (1992) 19(5):473–479 Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). Am J Kidney Dis (1992) 19(5):473–479
7.
Zurück zum Zitat Austin HA III, Boumpas DT, Vaughan EM, Balow JE (1994) Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 45(2):544–550PubMedCrossRef Austin HA III, Boumpas DT, Vaughan EM, Balow JE (1994) Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 45(2):544–550PubMedCrossRef
8.
Zurück zum Zitat Derksen RH, Hene RJ, Kater L (1992) The long-term clinical outcome of 56 patients with biopsy-proven lupus nephritis followed at a single center. Lupus 1(2):97–103PubMedCrossRef Derksen RH, Hene RJ, Kater L (1992) The long-term clinical outcome of 56 patients with biopsy-proven lupus nephritis followed at a single center. Lupus 1(2):97–103PubMedCrossRef
9.
Zurück zum Zitat Ward MM, Studenski S (1992) Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med 152(10):2082–2088PubMedCrossRef Ward MM, Studenski S (1992) Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med 152(10):2082–2088PubMedCrossRef
10.
Zurück zum Zitat Levey AS, Lan SP, Corwin HL, Kasinath BS, Lachin J, Neilson EG et al (1992) Progression and remission of renal disease in the lupus nephritis collaborative study. Results of treatment with prednisone and short-term oral cyclophosphamide. Ann Intern Med 116(2):114–123PubMed Levey AS, Lan SP, Corwin HL, Kasinath BS, Lachin J, Neilson EG et al (1992) Progression and remission of renal disease in the lupus nephritis collaborative study. Results of treatment with prednisone and short-term oral cyclophosphamide. Ann Intern Med 116(2):114–123PubMed
11.
Zurück zum Zitat Moroni G, Pasquali S, Quaglini S, Banfi G, Casanova S, Maccario M et al (1999) Clinical and prognostic value of serial renal biopsies in lupus nephritis. Am J Kidney Dis 34(3):530–539PubMedCrossRef Moroni G, Pasquali S, Quaglini S, Banfi G, Casanova S, Maccario M et al (1999) Clinical and prognostic value of serial renal biopsies in lupus nephritis. Am J Kidney Dis 34(3):530–539PubMedCrossRef
12.
Zurück zum Zitat Esdaile JM, Joseph L, MacKenzie T, Kashgarian M, Hayslett JP (1993) The pathogenesis and prognosis of lupus nephritis: information from repeat renal biopsy. Semin Arthritis Rheum 23(2):135–148PubMedCrossRef Esdaile JM, Joseph L, MacKenzie T, Kashgarian M, Hayslett JP (1993) The pathogenesis and prognosis of lupus nephritis: information from repeat renal biopsy. Semin Arthritis Rheum 23(2):135–148PubMedCrossRef
13.
Zurück zum Zitat Yoo CW, Kim MK, Lee HS (2000) Predictors of renal outcome in diffuse proliferative lupus nephropathy: data from repeat renal biopsy. Nephrol Dial Transplant 15(10):1604–1608PubMedCrossRef Yoo CW, Kim MK, Lee HS (2000) Predictors of renal outcome in diffuse proliferative lupus nephropathy: data from repeat renal biopsy. Nephrol Dial Transplant 15(10):1604–1608PubMedCrossRef
14.
Zurück zum Zitat Austin HA III, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH et al (1983) Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 75(3):382–391PubMedCrossRef Austin HA III, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH et al (1983) Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 75(3):382–391PubMedCrossRef
15.
Zurück zum Zitat Hill GS, Delahousse M, Nochy D, Remy P, Mignon F, Mery JP et al (2001) Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages. Kidney Int 59(1):304–316PubMedCrossRef Hill GS, Delahousse M, Nochy D, Remy P, Mignon F, Mery JP et al (2001) Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages. Kidney Int 59(1):304–316PubMedCrossRef
16.
Zurück zum Zitat Tam LS, Li EK, Lai FM, Chan YK, Szeto CC (2003) Mesangial lupus nephritis in Chinese is associated with a high rate of transformation to higher grade nephritis. Lupus 12(9):665–671PubMedCrossRef Tam LS, Li EK, Lai FM, Chan YK, Szeto CC (2003) Mesangial lupus nephritis in Chinese is associated with a high rate of transformation to higher grade nephritis. Lupus 12(9):665–671PubMedCrossRef
17.
Zurück zum Zitat Daleboudt GM, Bajema IM, Goemaere NN, van Laar JM, Bruijn JA, Berger SP (2009) The clinical relevance of a repeat biopsy in lupus nephritis flares. Nephrol Dial Transplant 24(12):3712–3717PubMedCrossRef Daleboudt GM, Bajema IM, Goemaere NN, van Laar JM, Bruijn JA, Berger SP (2009) The clinical relevance of a repeat biopsy in lupus nephritis flares. Nephrol Dial Transplant 24(12):3712–3717PubMedCrossRef
18.
Zurück zum Zitat Kim YG, Kim HW, Cho YM, Oh JS, Nah SS, Lee CK et al (2008) The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment. Rheumatology (Oxford) 47(3):311–314CrossRef Kim YG, Kim HW, Cho YM, Oh JS, Nah SS, Lee CK et al (2008) The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment. Rheumatology (Oxford) 47(3):311–314CrossRef
19.
Zurück zum Zitat Yu F, Tan Y, Wu LH, Zhu SN, Liu G, Zhao MH (2009) Class IV-G and IV-S lupus nephritis in Chinese patients: a large cohort study from a single center. Lupus 18(12):1073–1081PubMedCrossRef Yu F, Tan Y, Wu LH, Zhu SN, Liu G, Zhao MH (2009) Class IV-G and IV-S lupus nephritis in Chinese patients: a large cohort study from a single center. Lupus 18(12):1073–1081PubMedCrossRef
20.
Zurück zum Zitat Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J (2001) Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 59(6):2156–2163PubMed Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J (2001) Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 59(6):2156–2163PubMed
21.
Zurück zum Zitat Mittal B, Hurwitz S, Rennke H, Singh AK (2004) New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences? Am J Kidney Dis 44(6):1050–1059PubMedCrossRef Mittal B, Hurwitz S, Rennke H, Singh AK (2004) New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences? Am J Kidney Dis 44(6):1050–1059PubMedCrossRef
22.
Zurück zum Zitat Hill GS, Delahousse M, Nochy D, Bariety J (2005) Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis. Kidney Int 68(5):2288–2297PubMedCrossRef Hill GS, Delahousse M, Nochy D, Bariety J (2005) Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis. Kidney Int 68(5):2288–2297PubMedCrossRef
23.
Zurück zum Zitat Markowitz GS, D’Agati VD (2009) Classification of lupus nephritis. Curr Opin Nephrol Hypertens 18(3):220–225PubMedCrossRef Markowitz GS, D’Agati VD (2009) Classification of lupus nephritis. Curr Opin Nephrol Hypertens 18(3):220–225PubMedCrossRef
24.
Zurück zum Zitat Yu F, Wu LH, Tan Y, Li LH, Wang CL, Wang WK et al (2010) Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Kidney Int 77(9):820–829PubMedCrossRef Yu F, Wu LH, Tan Y, Li LH, Wang CL, Wang WK et al (2010) Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Kidney Int 77(9):820–829PubMedCrossRef
25.
Zurück zum Zitat Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR et al (2010) Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303(5):423–429PubMedCrossRef Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR et al (2010) Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303(5):423–429PubMedCrossRef
26.
Zurück zum Zitat Hill GS, Delahousse M, Nochy D, Mandet C, Bariety J (2001) Proteinuria and tubulointerstitial lesions in lupus nephritis. Kidney Int 60(5):1893–1903PubMedCrossRef Hill GS, Delahousse M, Nochy D, Mandet C, Bariety J (2001) Proteinuria and tubulointerstitial lesions in lupus nephritis. Kidney Int 60(5):1893–1903PubMedCrossRef
27.
Zurück zum Zitat Wu CT, Fu LS, Wen MC, Hung SC, Chi CS (2003) Lupus vasculopathy combined with acute renal failure in lupus nephritis. Pediatr Nephrol 18(12):1304–1307PubMedCrossRef Wu CT, Fu LS, Wen MC, Hung SC, Chi CS (2003) Lupus vasculopathy combined with acute renal failure in lupus nephritis. Pediatr Nephrol 18(12):1304–1307PubMedCrossRef
28.
Zurück zum Zitat Norman JT, Clark IM, Garcia PL (2000) Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 58(6):2351–2366PubMedCrossRef Norman JT, Clark IM, Garcia PL (2000) Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 58(6):2351–2366PubMedCrossRef
29.
Zurück zum Zitat Esdaile JM, Joseph L, MacKenzie T, Kashgarian M, Hayslett JP (1994) The benefit of early treatment with immunosuppressive agents in lupus nephritis. J Rheumatol 21(11):2046–2051PubMed Esdaile JM, Joseph L, MacKenzie T, Kashgarian M, Hayslett JP (1994) The benefit of early treatment with immunosuppressive agents in lupus nephritis. J Rheumatol 21(11):2046–2051PubMed
Metadaten
Titel
Characteristics and influence factors of pathologic transformation in the subclasses of class IV lupus nephritis
verfasst von
Jian-jun Gao
Guang-yan Cai
Shu-wen Liu
Li Tang
Xue-guang Zhang
Yang Yang
Pu Chen
Shu-xin Liu
Jia-yao Ji
Suo-zhu Shi
Zhong Yin
Xiang-mei Chen
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 6/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1899-6

Weitere Artikel der Ausgabe 6/2012

Rheumatology International 6/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.